Kahn, J. M., Mauz-Korholz, C., Hernandez, T., Milgrom, S. A., & Castellino, S. M. (2024). Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making. American Society of Clinical Oncology Educational Book, 44(3). https://doi.org/10.1200/edbk_432420

Mellgard, G., Stoffel, E., Michel, A., Iqbal, F., Provenzano, A., Akpan, I. J., Amengual, J., & Pro, B. (2023). Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma. Leukemia & Lymphoma, 64(13), 2208–2213. https://doi.org/10.1080/10428194.2023.2252124

Castellino, S. M., Giulino‐Roth, L., Harker‐Murray, P., Kahn, J. M., Forlenza, C., Cho, S., Hoppe, B., Parsons, S. K., & Kelly, K. M. (2023). Children’s Oncology Group’s 2023 blueprint for research: Hodgkin lymphoma. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30580

Allen, P. B., Lu, X., Chen, Q., O’Shea, K., Chmiel, J. S., Slonim, L. B., Sukhanova, M., Savas, H., Evens, A. M., Advani, R., Pro, B., Karmali, R., Palmer, B., Bayer, R. A., Eisner, R. M., Mou, E., Dillehay, G., Gordon, L. I., & Winter, J. N. (2023). Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma. Blood Advances, 7(12), 2670–2676. https://doi.org/10.1182/bloodadvances.2022008116

Manson, G., Lemchukwu, A. C., Mokrane, F.-Z., Lopci, E., Aide, N., Vercellino, L., Houot, R., & Dercle, L. (2022). Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors. European Radiology, 32(9), 6536–6544. https://doi.org/10.1007/s00330-022-08669-8

Kahn, J. M., Zhang, X., Kahn, A. R., Castellino, S. M., Neugut, A. I., Schymura, M. J., Boscoe, F. P., & Keegan, T. H. M. (2022). Racial Disparities in Children, Adolescents, and Young Adults with Hodgkin Lymphoma Enrolled in the New York State Medicaid Program. Journal of Adolescent and Young Adult Oncology, 11(4), 360–369. https://doi.org/10.1089/jayao.2021.0131

Kahn, J. M., Pei, Q., Friedman, D. L., Kaplan, J., Keller, F. G., Hodgson, D., Wu, Y., Appel, B. E., Bhatia, S., Henderson, T. O., Schwartz, C. L., Kelly, K. M., & Castellino, S. M. (2022). Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children’s oncology group trials. The Lancet Haematology, 9(1), e49–e57. https://doi.org/10.1016/s2352-3026(21)00349-5

Kahn, J. M., Maguire, F. B., Li, Q., Abrahão, R., Flerlage, J. E., Alvarez, E., & Keegan, T. H. M. (2021). Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population‐based study. Cancer, 127(24), 4613–4619. Portico. https://doi.org/10.1002/cncr.33868

Unger, J. M., Beauchemin, M., & Hershman, D. L. (2021). Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years. Cancer, 127(24), 4574–4584. Portico. https://doi.org/10.1002/cncr.33855